Cargando…
Compositional and genetic alterations in Graves’ disease gut microbiome reveal specific diagnostic biomarkers
Graves’ Disease is the most common organ-specific autoimmune disease and has been linked in small pilot studies to taxonomic markers within the gut microbiome. Important limitations of this work include small sample sizes and low-resolution taxonomic markers. Accordingly, we studied 162 gut microbio...
Autores principales: | Zhu, Qiyun, Hou, Qiangchuan, Huang, Shi, Ou, Qianying, Huo, Dongxue, Vázquez-Baeza, Yoshiki, Cen, Chaoping, Cantu, Victor, Estaki, Mehrbod, Chang, Haibo, Belda-Ferre, Pedro, Kim, Ho-Cheol, Chen, Kaining, Knight, Rob, Zhang, Jiachao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528855/ https://www.ncbi.nlm.nih.gov/pubmed/34079079 http://dx.doi.org/10.1038/s41396-021-01016-7 |
Ejemplares similares
-
Correction to: Compositional and genetic alterations in Graves’ disease gut microbiome reveal specific diagnostic biomarkers
por: Zhu, Qiyun, et al.
Publicado: (2022) -
The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves’ Disease Patients Through Regulating the Intestinal Microbiome
por: Han, Zhe, et al.
Publicado: (2022) -
Probiotic Bifidobacterium longum supplied with methimazole improved the thyroid function of Graves’ disease patients through the gut-thyroid axis
por: Huo, Dongxue, et al.
Publicado: (2021) -
Candidate probiotic Lactiplantibacillus plantarum HNU082 rapidly and convergently evolves within human, mice, and zebrafish gut but differentially influences the resident microbiome
por: Huang, Shi, et al.
Publicado: (2021) -
QIIME 2 Enables Comprehensive End‐to‐End Analysis of Diverse Microbiome Data and Comparative Studies with Publicly Available Data
por: Estaki, Mehrbod, et al.
Publicado: (2020)